GenScript Biotech Acquires CustomArray to Expand Synthetic Biology Product Portfolio – PR Newswire (press release)
|
GenScript Biotech Acquires CustomArray to Expand Synthetic Biology Product Portfolio
PR Newswire (press release) “The acquisition of CustomArray further strengthens our synthetic biology product portfolio with a unique technology that we believe will enhance our customers’ ability to accelerate innovation in drug discovery and development, genome editing, protein … |
|
Toxicities associated with immunotherapy warrant ‘very high level of suspicion’
Healio Since 2011, the FDA has approved six immune checkpoint inhibitors designed to reverse the course of multiple cancers. Those approvals — along with oncologists’ willingness to combine immunotherapies — has led to more durable responses among patients … |
|
Beyond Crispr -Cas9 Gene editing
Next Big Future RNA are the instructions that a cell’s machinery reads to build proteins. RNA would be useful for treating short-term problems like acute inflammation or wounds. The system is called calling Repair (RNA Editing for Programmable A to I Replacement). It … |